Recommended Products
form
powder
IVD
for in vitro diagnostic use
concentration
10 ×
pH
7.0-7.8
application(s)
hematology
histology
storage temp.
room temp
Application
Used as a "blueing reagent" in hematoxylin and eosin staining procedures. Scott′s Tap Water Substitute Concentrate has been used in transferase−mediated dUTP nick end labeling (TUNEL) assay. It has been used in immunohistochemical analysis.
Other Notes
MgSO4 • 7H2O, 200 g/L + NaHCO3, 20 g/L
Preparation Note
Scott′s Tap Water Substitute is prepared by mixing 1 part of Scott′s Tap Water Substitute Concentrate with 9 parts deionized water.
Signal Word
Warning
Hazard Statements
Precautionary Statements
Hazard Classifications
Aquatic Chronic 2 - Eye Irrit. 2 - Skin Irrit. 2 - Skin Sens. 1
Storage Class Code
10 - Combustible liquids
WGK
WGK 3
Personal Protective Equipment
dust mask type N95 (US), Eyeshields, Gloves
Certificates of Analysis (COA)
Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Customers Also Viewed
Intermittent metronomic drug schedule is essential for activating antitumor innate immunity and tumor xenograft regression
Chen CS, et al.
Neoplasia, 16(1), W22-W27 (2014)
Impact of tumor vascularity on responsiveness to antiangiogenesis in a prostate cancer stem cell-derived tumor model
Zhang, et al.
Molecular Cancer Therapeutics (2013)
Histophatologic Techniques (2006)
Beth G Ashinsky et al.
Acta biomaterialia, 111, 232-241 (2020-05-25)
Tissue-engineered replacement discs are an area of intense investigation for the treatment of end-stage intervertebral disc (IVD) degeneration. These living implants can integrate into the IVD space and recapitulate native motion segment function. We recently developed a multiphasic tissue-engineered disc-like
Zollie A Yavarow et al.
Human molecular genetics, 29(2), 286-294 (2019-12-10)
Glycogen storage disease type Ia (GSD Ia) is caused by autosomal mutations in glucose-6-phosphatase α catalytic subunit (G6PC) and can present with severe hypoglycemia, lactic acidosis and hypertriglyceridemia. In both children and adults with GSD Ia, there is over-accumulation of
Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.
Contact Technical Service